Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Innovent Biologics Inc.

    OTC: IVBXF · Real-Time Price · USD
    12.73
    0.03 (0.24%)
    At close: Aug 22, 2025, 12:53 PM
    12.70
    -0.24%
    After-hours: Aug 21, 2025, 04:00 PM EDT

    Innovent Biologics Income Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 9.42B 7.46B 6.21B 5.02B 4.56B 4.57B 4.27B 4.8B
    Cost of Revenue
    		 2.41B 2.12B 1.81B 1.46B 1.38B 1.38B 1.22B 1.01B
    Gross Profit
    		 7.01B 5.34B 4.4B 3.56B 3.17B 3.19B 3.05B 3.79B
    Operating Income
    		 -755.87M -1.7B -1.68B -2.39B -3.12B -3.17B -2.7B -761.58M
    Interest Income
    		 n/a 48.33M 98.62M 182.7M 132.41M 142.8M 142.8M 95.44M
    Pretax Income
    		 -78.62M -1.28B -1.14B -1.43B -2.17B -2.64B -2.64B -1.26B
    Net Income
    		 -94.63M -1.28B -1.03B -1.37B -2.18B -2.68B -2.73B -1.39B
    Selling & General & Admin
    		 5.08B 4.33B 3.85B 3.34B 3.43B 3.84B 3.43B 2.54B
    Research & Development
    		 2.68B 2.7B 2.23B 2.62B 2.87B 2.52B 2.32B 2.02B
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 7.77B 7.04B 5.57B 5.07B 5.43B 5.9B 5.78B 5.1B
    Interest Expense
    		 n/a n/a n/a n/a 44.57M 157.07M 139.61M 27.1M
    Selling & Marketing Expenses
    		 4.35B 3.63B 3.1B 2.54B 2.59B 2.93B 2.62B 1.98B
    Cost & Expenses
    		 10.18B 9.16B 7.37B 6.53B 6.81B 7.28B 7B 6.11B
    Income Tax Expense
    		 16.01M 497K 117.42M 174.21M 105.69M 135.33M 87.04M 136.33M
    Shares Outstanding (Basic)
    		 1.67B 1.62B 1.58B 1.54B 1.52B 1.46B 1.45B 1.45B
    Shares Outstanding (Diluted)
    		 1.63B 1.62B 1.58B 1.54B 1.52B 1.47B 1.46B 1.45B
    EPS (Basic)
    		 -0.06 -0.8 -0.65 -0.91 -1.46 -1.82 -1.88 -0.98
    EPS (Diluted)
    		 -0.06 -0.8 -0.65 -0.91 -1.46 -1.82 -1.88 -0.98
    EBITDA
    		 -480.28M -990.62M -1.29B -2.08B -2.88B -2.98B -2.54B -663.59M
    EBIT
    		 -755.87M -1.28B -1.56B -2.39B -3.12B -3.17B -2.7B -761.58M
    Depreciation & Amortization
    		 275.6M 286.8M 275.6M 312.14M 245.09M 192.89M 165.4M 97.99M

    Add to Watchlist